Advanced search
Publication Cover
Expert Review of Clinical Pharmacology Volume 15, 2022 - Issue 3
Submit an article Journal homepage
7,050
Views
3
CrossRef citations to date
0
Altmetric
Drug Profile

Pharmacological profile of once-weekly injectable semaglutide for chronic weight management

David C. W. Laua Biochemistry and Molecular Biology, Department of Medicine, University of Calgary Cumming School of Medicine, Calgary, Alberta, CanadaCorrespondence[email protected]
View further author information
,
Rachel L Batterhamb Centre for Obesity Research, Department of Medicine, University College London, London, UK;c Bariatric Centre for Weight Management and Metabolic Surgery, University College London Hospital, London, UK;d National Institute for Health Research, Biomedical Research Centre, University College London Hospital, London, UKView further author information
&
Carel W. le Rouxe School of Medicine, University College Dublin, Dublin, IrelandORCID Iconhttps://orcid.org/0000-0001-5521-5445View further author information
ORCID Icon
Pages 251-268 | Received 04 Feb 2022, Accepted 22 Apr 2022, Published online: 27 Apr 2022

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Caroline J. Violette, Ravi Agarwal, Rachel S. Mandelbaum, José L. González, Kurt M. Hong, Lynda D. Roman, Maximilan Klar, Jason D. Wright, Richard J. Paulson, Andreas Obermair & Koji Matsuo. (2023) The potential role of GLP-1 receptor agonist targeting in fertility-sparing treatment in obese patients with endometrial malignant pathology: a call for research. Expert Review of Anticancer Therapy 23:4, pages 385-395.
Read now

Articles from other publishers (2)

Zhuqing Meng, Min Yang, Haibo Wen, Su Zhou, Chuan Xiong & Yu Wang. (2023) A systematic review of the safety of tirzepatide-a new dual GLP1 and GIP agonist - is its safety profile acceptable?. Frontiers in Endocrinology 14.
Crossref
Muhammad Ali Tariq, Hamza Amin, Qazi Shurjeel, Ahmed Gang & Ashar Mohiuddin. (2022) Gastrointestinal adverse events of semaglutide in patients with overweight or obesity. European Journal of Internal Medicine 106, pages 138-139.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.